日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Safety and efficacy of zandelisib plus zanubrutinib in previously treated follicular and mantle cell lymphomas

zandelisib联合zanubrutinib治疗既往接受过治疗的滤泡性淋巴瘤和套细胞淋巴瘤的安全性和有效性

期刊:British Journal of Haematology
影响因子:3.8
doi:10.1111/bjh.19419
Soumerai, Jacob D; Diefenbach, Catherine S; Jagadeesh, Deepa; Asch, Adam; Kumar, Abhijeet; Tsai, Michaela L; Jandl, Thomas A; Lossos, Izidore S; Kenkre, Vaishalee P; Awan, Farrukh; Novotny, William; Huang, Jane; Miao, Lu; Rajagopalan, Prabhu; Ghalie, Richard G; Zelenetz, Andrew D
细胞生物学
淋巴瘤
发表日期：2024
文献求助 收藏

Blood-based tumor mutational burden as a biomarker for atezolizumab in non-small cell lung cancer: the phase 2 B-F1RST trial

基于血液的肿瘤突变负荷作为阿特珠单抗治疗非小细胞肺癌的生物标志物：B-F1RST II期试验

期刊:Nature Medicine
影响因子:50
doi:10.1038/s41591-022-01754-x
Kim, Edward S; Velcheti, Vamsidhar; Mekhail, Tarek; Yun, Cindy; Shagan, Sarah M; Hu, Sylvia; Chae, Young Kwang; Leal, Ticiana A; Dowell, Jonathan E; Tsai, Michaela L; Dakhil, Christopher S R; Stella, Philip; Jin, Yanling; Shames, David S; Schleifman, Erica; Fabrizio, David A; Phan, See; Socinski, Mark A
肺癌
细胞生物学
肿瘤
肿瘤免疫
发表日期：2022
文献求助 收藏

HER2 Testing Characteristics Can Predict Residual Cancer Burden following Neoadjuvant Chemotherapy in HER2-Positive Breast Cancer

HER2检测特征可预测HER2阳性乳腺癌新辅助化疗后的残余癌负荷

期刊:International Journal of Breast Cancer
影响因子:3
doi:10.1155/2021/6684629
Lillemoe, Tamera J; Rendi, Mara; Tsai, Michaela L; Knaack, Monica; Yarosh, Rina; Grimm, Erin; Susnik, Barbara; Krueger, Janet; Olet, Susan; Swenson, Karen K
HER2
肿瘤
肿瘤免疫
乳腺癌
发表日期：2021
文献求助 收藏

Liquid biopsy mutation panel for non-small cell lung cancer: analytical validation and clinical concordance

非小细胞肺癌液体活检突变谱：分析验证和临床一致性

期刊:npj Precision Oncology
影响因子:8
doi:10.1038/s41698-020-0118-x
Schwartzberg, Lee S; Horinouchi, Hidehito; Chan, David; Chernilo, Sara; Tsai, Michaela L; Isla, Dolores; Escriu, Carles; Bennett, John P; Clark-Langone, Kim; Svedman, Christer; Tomasini, Pascale
肺癌
细胞生物学
肿瘤
肿瘤免疫
发表日期：2020
文献求助 收藏

Serum Markers of Bone Turnover and Angiogenesis in Patients With Bisphosphonate-Related Osteonecrosis of the Jaw After Discontinuation of Long-Term Intravenous Bisphosphonate Therapy.

长期静脉注射双膦酸盐治疗停止后，双膦酸盐相关性颌骨坏死患者的骨转换和血管生成血清标志物

期刊:Journal of Oral and Maxillofacial Surgery
影响因子:2.6
doi:10.1016/j.joms.2015.09.028
Thumbigere-Math Vivek, Michalowicz Bryan S, Hughes Pamela J, Basi David L, Tsai Michaela L, Swenson Karen K, Rockwell Laura, Gopalakrishnan Rajaram
骨科研究
Angiogenesis
血管生成
发表日期：2016
文献求助 收藏

Periodontal disease as a risk factor for bisphosphonate-related osteonecrosis of the jaw

牙周病是双膦酸盐相关颌骨坏死的危险因素

期刊:Journal of Periodontology
影响因子:3.8
doi:10.1902/jop.2013.130017
Thumbigere-Math, Vivek; Michalowicz, Bryan S; Hodges, James S; Tsai, Michaela L; Swenson, Karen K; Rockwell, Laura; Gopalakrishnan, Rajaram
发表日期：2014
文献求助 收藏